Medical Devices

Structural Heart Devices Market by Product (Structural Heart Repair Devices and Replacement Valves), Age Group (Pediatric and Adult), and Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • ALL895726
  • 230 Pages
  • February 2017
  • Medical Devices

Structural heart disease refers to cardiac defects that are congenital in nature and can also be acquired through wear & tear of heart valves or chambers of the heart. Rapid advancements in the medical field have replaced the open heart surgical procedures with non-surgical minimally invasive procedures such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR).

Currently, the global structural heart devices market is growing at a steady pace owing to the rise in incidence of structural heart diseases (aortic stenosis and mitral regurgitation) and development of minimally invasive technologies. According to the Micro Interventional Devices, Inc., about 60 million people in the U.S. suffer from structural heart defects. Moreover, as per the National Heart, Lung and Blood Institute, more than 35,000 babies are born with congenital heart defects in the U.S. These estimates are expected to boost the demand for structural heart devices during the forecast period. High cost of surgeries, risks associated with these surgeries, and lack of skilled cardiologists restrict this market growth. However, emerging markets (India and China) and increase in demand for structural heart procedures are expected to provide lucrative opportunities to the key players.  The structural heart devices market is projected to reach $12,076 million by 2022 from $6,006 million in 2015, growing at a CAGR of 10.5% from 2016 to 2022.

The report segments the market based on product type, indication, age group, and geography. Based on product type, the market is bifurcated into repair devices (annuloplasty rings, heart valve balloons, and occluders) and replacement valves (mechanical and tissue heart valves]. Based on indication, it is divided into atrial septal defect (ASD), patent foramen ovale (PFO), and ventricular septal defect (VSD), aortic valve stenosis, and others. In terms of age group, it is further categorized as pediatrics and adults. The pediatrics’ age group is segmented into newborns (0‐5 months), infants (6 months to 12 months), toddlers (1‐2 years), preschoolers (3‐5 years), school-aged children (6‐12 years), and adolescents (13‐18 years). The adult age group market is further segmented into young adults (19‐24 years), adulthood (25‐39 years), middle-aged (40‐59 years), older people/old age (60‐84 years), and very old (85+ years). Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.


  • The study provides an in-depth analysis of the structural heart devices market, along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It presents a quantitative analysis from 2014 to 2022 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on products helps to understand the type of devices used to treat structural heart diseases.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographical regions determines the prevailing opportunities in these regions.
  • Key players and their strategies are analyzed to understand the competitive outlook of the overall market.
  • Extensive analysis is conducted by following key product positioning and monitoring the top contenders within the market framework.


By Product

  • Repair Devices                    
    • Annuloplasty Rings                
    • Heart Valve Balloons            
    • Occluders                
  • Replacement Valves                                    
    • Mechanical Heart Valves
    • Tissue Heart Valves                        

By Indication

  • Atrial Septal Defect (ASD)
  • Ventricular Septal Defect (VSD)
  • Patent Foramen Ovale (PFO)
  • Aortic Valve Stenosis
  • Others

By Age Group

  • Pediatric
    • Newborns (0‐5 months)
    • Infants (6 months to 12 months)
    • Toddlers (1‐2 years)
    • Preschoolers (3‐5 years)
    • School-aged children (6‐12 years)
    • Adolescents (13‐18)
  • Adults
    • Young Adults (19‐24 years)
    • Adulthood (25‐39 years)
    • Middle-aged Persons (40‐59 years)
    • Older People/Old Age (60‐84 years)
    • Very Old (85+ years)

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
    • Brazil
    • South Africa
    • Israel
    • Saudi Arabia
    • Rest of LAMEA

List of key players profiled in the report

  • Medtronic plc
  • St. Jude Medical, Inc.
  • Braile Biomedica
  • Medical Technology Est.
  • Boston Scientific Corporation
  • Micro Interventional Devices, Inc.
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • JenaValve Technology, Inc.
  • Cryolife, Inc.

List of other players in the value chain (profiles not included in the report)

  • Corvia Medical, Inc.
  • CardioKinetix, Inc.
  • Biomerics, LLC
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Comed B.V.
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+91 20 66346066
--- or ---



World Anesthesia Monitoring Devices Market - Opportunities and Forecasts, 2014 - 2020

Anesthesia can be monitored depending on the types of cases performed for the purpose of continuous assessment of the patients by measuring parameters such as patients oxygenation, circulation, ventilation, and temperature. It is logical that other clinical observations be supplemented to different monitoring devices.

April 2018| $5370 | Pre Book Price:$4699

World Anti-Snoring Devices and Snoring Surgery Market - Opportunities and Forecasts, 2014 - 2020

The anti-snoring devices and snoring surgery market has gained traction in the recent years due to growing consciousness about the ill effects of snoring and sleep apnea, and these treatments ...

April 2018| $5370 | Pre Book Price:$4699

World Sports Medicine Market - Opportunities and Forecasts, 2014 - 2020

The sports medicine market consists of products used by athletes or sportspersons to prevent injuries and protect themselves including devices that boost performance. The product offerings play a crucial role in the rehabilitation, recovery, endurance, and monitoring of athletes in sports.

April 2018| $5370 | Pre Book Price:$4699

World 3D Printing Medical Devices Market - Opportunities and Forecasts, 2014 - 2020

Large patient population, expansion of distribution networks by the key market players, awareness about benefits of 3D printing technology and its adoption across the emerging countries in Asia-Pacific are the ...

April 2018| $5370 | Pre Book Price:$4699

World Veterinary Imaging Market - Opportunities and Forecasts, 2014 - 2020

Veterinary diagnostic imaging consists of a non-invasive method of obtaining images of the animal body for the purpose of medical diagnostics. The animals considered for imaging are small companion animals, ...

April 2018| $5370 | Pre Book Price:$4699

BRIC Diabetes Care Devices Market - Opportunities and Forecasts, 2014 - 2020

Diabetes care devices helps in the management of blood glucose levels caused in patients due to inadequate insulin production or insulin resistance. The Diabetes Care Devices Market in Brazil, Russia, ...

April 2018| $5370 | Pre Book Price:$4699

2018 © Copyright Big Market Research

View Pricing >>